254 related articles for article (PubMed ID: 29143356)
21. [Use in France of Baclofen for Alcohol Dependence from 2007 to 2013: Cohort Study Based on the Databases SNIIRAM and PMSI].
Chaignot C; Weill A; Ricordeau P; Alla F
Therapie; 2015; 70(5):443-53. PubMed ID: 26423143
[TBL] [Abstract][Full Text] [Related]
22. [Baclofen and liver cirrhosis: literature review and safety precautions implemented within the system CAMTEA].
Rolland B; Deheul S; Louvet A; Gautier S; Cottencin O; Bordet R;
Therapie; 2014; 69(2):143-7. PubMed ID: 24926632
[TBL] [Abstract][Full Text] [Related]
23. Hospital pharmacists' perceived beliefs and responsibilities in indication-based off-label prescribing.
Basak R; McCaffrey DJ
Int J Clin Pharm; 2018 Feb; 40(1):36-40. PubMed ID: 29204800
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
[TBL] [Abstract][Full Text] [Related]
25. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
[TBL] [Abstract][Full Text] [Related]
26. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.
Matheson C; Bond CM; Hickey F
Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708
[TBL] [Abstract][Full Text] [Related]
27. Gambling disorder: a side effect of an off-label prescription of baclofen-literature review.
Guillou-Landreat M; Victorri Vigneau C; Gerardin M
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28073872
[TBL] [Abstract][Full Text] [Related]
28. Off-label prescribing in a French hospital.
Cras A; Conscience MA; Rajzbaum G; Lillo-Le Louët A; Lopez N; Tersen I; Bezie Y
Pharm World Sci; 2007 Apr; 29(2):97-100. PubMed ID: 17160629
[TBL] [Abstract][Full Text] [Related]
29. What to do when presented with a prescription from another European country: insight from a qualitative study of pharmacists in England.
Knai C; Saliba V; Davies J; McKee M; Khoshaba B; Lago E; San Miguel L
Int J Pharm Pract; 2014 Apr; 22(2):112-8. PubMed ID: 23849254
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations.
Rupp MT; Warholak TL
J Am Pharm Assoc (2003); 2008; 48(3):364-70. PubMed ID: 18595821
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of Patients with Alcohol Dependence Seeking Baclofen Treatment in France: A Two-Centre Comparative Cohort Study.
Simioni N; Preda C; Deken V; Bence C; Cottencin O; Rolland B
Alcohol Alcohol; 2016 Nov; 51(6):664-669. PubMed ID: 26988996
[TBL] [Abstract][Full Text] [Related]
32. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
[TBL] [Abstract][Full Text] [Related]
33. Dispensing practice in the community pharmacies in the Turkish Republic of Northern Cyprus.
Gokcekus L; Toklu HZ; Demirdamar R; Gumusel B
Int J Clin Pharm; 2012 Apr; 34(2):312-24. PubMed ID: 22262499
[TBL] [Abstract][Full Text] [Related]
34. [Cooperation according to French Law "hospital, patients, health and territories": Pharmacists' involvement in Aquitaine region].
d'Elbée M; Baumevieille M; Dumartin C
Rev Epidemiol Sante Publique; 2017 Jun; 65(3):231-239. PubMed ID: 28262371
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
36. The role of perceived impact on relationship quality in pharmacists' willingness to influence indication-based off-label prescribing decisions.
Basak R; Bentley JP; McCaffrey DJ; Bouldin AS; Banahan BF
Soc Sci Med; 2015 May; 132():181-9. PubMed ID: 25818379
[TBL] [Abstract][Full Text] [Related]
37. [The community pharmacist and the problem of excessive drinkers].
Pouyet-Poulet E; Sauvant MP; Pépin D; Planche R
Sante Publique; 2001 Sep; 13(3):237-48. PubMed ID: 11826843
[TBL] [Abstract][Full Text] [Related]
38. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
39. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
40. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Mukattash T; Hawwa AF; Trew K; McElnay JC
Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
